LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $446,000 | +4.4% | 3,400 | +21.4% | 0.02% | -11.8% |
| Q1 2021 | $427,000 | +53.6% | 2,800 | 0.0% | 0.02% | +41.7% |
| Q4 2020 | $278,000 | -11.7% | 2,800 | -15.2% | 0.01% | -20.0% |
| Q3 2020 | $315,000 | -27.8% | 3,300 | -15.4% | 0.02% | -28.6% |
| Q2 2020 | $436,000 | +53.5% | 3,900 | 0.0% | 0.02% | +23.5% |
| Q1 2020 | $284,000 | -22.2% | 3,900 | +11.4% | 0.02% | +13.3% |
| Q4 2019 | $365,000 | +4.9% | 3,500 | 0.0% | 0.02% | -6.2% |
| Q3 2019 | $348,000 | -13.0% | 3,500 | 0.0% | 0.02% | -5.9% |
| Q2 2019 | $400,000 | -26.1% | 3,500 | -18.6% | 0.02% | -26.1% |
| Q1 2019 | $541,000 | -7.4% | 4,300 | 0.0% | 0.02% | -17.9% |
| Q4 2018 | $584,000 | – | 4,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |